123 related articles for article (PubMed ID: 37393022)
21. Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
Corry J; Ng WT; Moore A; Choi HCW; Le Q; Holmes S; Munandar A; Wang S; Camacho A; Setakornnukul J; Jiarpinitnun C; Hiep PN; Laskar SG; Benjaafar N; Faheem M; Jin F; Ammar CNB; Ali R; Boualga K; Abdelwahab S; Sommat K; Tao Y; O'Sullivan B; Lee N; Zubizaretta E; Prajogi B; Hopkins K; Rosenblatt E; Lee AWM
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1227-1236. PubMed ID: 34418466
[TBL] [Abstract][Full Text] [Related]
22. Prostate radiotherapy clinical trial quality assurance: how real should real time review be? (A TROG-OCOG Intergroup Project).
Martin J; Frantzis J; Chung P; Langah I; Crain M; Cornes D; Plank A; Finch T; Jones M; Khoo E; Catton C
Radiother Oncol; 2013 Jun; 107(3):333-8. PubMed ID: 23751377
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.
Knight G; Earle CC; Cosby R; Coburn N; Youssef Y; Malthaner R; Wong RK;
Gastric Cancer; 2013 Jan; 16(1):28-40. PubMed ID: 22467061
[TBL] [Abstract][Full Text] [Related]
24. Improving target volume delineation in intact cervical carcinoma: Literature review and step-by-step pictorial atlas to aid contouring.
Eminowicz G; Hall-Craggs M; Diez P; McCormack M
Pract Radiat Oncol; 2016; 6(5):e203-e213. PubMed ID: 27032573
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.
Abrunhosa-Branquinho AN; Bar-Deroma R; Collette S; Clementel E; Liu Y; Hurkmans CW; Feuvret L; Van Beek K; van den Bent M; Baumert BG; Weber DC
Radiother Oncol; 2018 May; 127(2):292-298. PubMed ID: 29606522
[TBL] [Abstract][Full Text] [Related]
26. Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
Christiaens M; Collette S; Overgaard J; Gregoire V; Kazmierska J; Castadot P; Giralt J; Grant W; Tomsej M; Bar-Deroma R; Monti AF; Hurkmans CW; Weber DC
Radiother Oncol; 2017 Jun; 123(3):424-430. PubMed ID: 28478912
[TBL] [Abstract][Full Text] [Related]
27. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience.
Allen CJ; Blumenthaler AN; Smith GL; Das P; Minsky BD; Blum M; Ajani J; Mansfield PF; Ikoma N; Badgwell BD
Ann Surg Oncol; 2021 Feb; 28(2):758-765. PubMed ID: 32696305
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial.
Khaw P; Do V; Lim K; Cunninghame J; Dixon J; Vassie J; Bailey M; Johnson C; Kahl K; Gordon C; Cook O; Foo K; Fyles A; Powell M; Haie-Meder C; D'Amico R; Bessette P; Mileshkin L; Creutzberg CL; Moore A
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):198-204. PubMed ID: 34903431
[TBL] [Abstract][Full Text] [Related]
30. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.
de Rojas T; Clementel E; Giralt J; Cruz O; Boterberg T; Kortmann RD; Gaze MN; Moreno L; Janssens GO;
Eur J Cancer; 2019 Jun; 114():36-46. PubMed ID: 31035085
[TBL] [Abstract][Full Text] [Related]
32. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
33. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M; Zilli T; Dubouloz A; Escude L; Jorcano S; Linthout N; Bral S; Verbakel W; Bruynzeel A; Björkqvist M; Minn H; Tsvang L; Symon Z; Lencart J; Oliveira A; Ozen Z; Abacioglu U; Pérez-Moreno JM; Rubio C; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1047-1054. PubMed ID: 32535161
[TBL] [Abstract][Full Text] [Related]
34. [Gastric and pancreatic cancers: Will neoadjuvant (chemo)radiotherapy replace adjuvant chemoradiotherapy?].
Huguet F; Rivin Del Campo E; Labidi M; Ménard J; Sergent G; Durand B; Quéro L
Cancer Radiother; 2020 Oct; 24(6-7):493-500. PubMed ID: 32814670
[TBL] [Abstract][Full Text] [Related]
35. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Choi AH; Kim J; Chao J
World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
[TBL] [Abstract][Full Text] [Related]
38. Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?
Jansen EP; Boot H; van de Velde CJ; van Sandick J; Cats A; Verheij M
Recent Results Cancer Res; 2012; 196():229-40. PubMed ID: 23129378
[TBL] [Abstract][Full Text] [Related]
39. Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial.
Shi J; Li N; Tang Y; Jiang L; Yang L; Wang S; Song Y; Liu Y; Fang H; Lu N; Qi S; Chen B; Li Z; Liu S; Wang J; Wang W; Zhu S; Yang J; Li Y; Zhao D; Jin J
BMC Gastroenterol; 2022 Jul; 22(1):359. PubMed ID: 35902798
[TBL] [Abstract][Full Text] [Related]
40. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
